位置:成果数据库 > 期刊 > 期刊详情页
Persistence of side population cells with high drug efflux capacity in pancreatic cancer
  • 时间:0
  • 分类:R735.9[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:[1]Institute of Pancreatic Surgery, Union Hospital, Huazhong University of Science and Technology, 1277 Jiefang Ave., Wuhan 430022, Hubei Province, China, [2]Department of Orthopaedics, Union Hospital, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan 430022, Hubei Province, China
  • 相关基金:Supported by The National Natural Science Foundation of China, No. 30571817 The authors are grateful to the technical assistance from the Research Laboratory of General Surgery, Union Hospital, Wuhan.
  • 相关项目:胰腺癌干细胞分离、鉴定及其关键调控分子表达研究
中文摘要:

瞄准:调查方面人口(SP ) 的坚持在在药抵抗的胰腺的癌症和他们的角色和机制的房间。方法:当有教养时,在胰腺的癌症房间线 PANC-1 和它的比例的方面人口房间的演讲随着 Gemcitabine 变化,被 Hoechst 33342 染色和 FACS 分析检测。ABCB1 和 ABCG2 的表示被即时 PCR 在 SP 房间或 non-SP 房间检测。结果:SP 房间确实在 PANC-1 存在,与一 3.3% 的 median 和 2.1-8.7% 的一个范围。在以后与为 3 d 的 Gemcitabine 有教养, SP 房间的比例显著地增加了(3.8%+/-1.9% , 10.7%+/-3.7% , t = 4.616, P = 0.001 【 0.05 ) 。在 SP 在更高的集中表示为与 non-SP 房间相比的 ABCB1 和 ABCG2 (ABCB1:1.15 +/- 0.72, 5.82 +/- 1.16, t = 10.839, P = 0.000 【 0.05;ABCG2:1.16 +/- 0.75, 5.48 +/- 0.94, t = 11.305, P = 0.000 【 0.05 ) ,它可以贡献荧光灯的染色和药抵抗的流出。结论:有到化学疗法的代理人的内在地高的抵抗的 SP 房间确实在胰腺的癌症存在,它可以是贡献肿瘤的恶化的候选人癌症干细胞。

英文摘要:

AIM: To investigate the persistence of side population (SP) cells in pancreatic cancer and their role and mechanism in the drug resistance. METHODS: The presentation of side population cells in pancreatic cancer cell line PANC-1 and its proportion change when cultured with Gemcitabine, was detected by Hoechst 33342 staining and FACS analysis. The expression of ABCB1 and ABCG2 was detected by real- time PCR in either SP cells or non-SP cells. RESULTS: SP cells do exist in PANC-1, with a median of 3.3% and a range of 2.1-8.7%. After cultured with Gemcitabine for 3 d, the proportion of SP cells increased significantly (3.8% ± 1.9%, 10.7% ± 3.7%, t = 4.616, P = 0.001 〈 0.05). ABCB1 and ABCG2 expressed at higher concentrations in SP as compared with non-SP cells (ABCB1: 1.15 ± 0.72, 5.82 ± 1.16, t = 10.839, P = 0.000 〈 0.05; ABCG2: 1.16 ± 0.75, 5.48 ± 0.94, t = 11.305, P = 0.000 〈 0.05), which may contribute to the efflux of fluorescent staining and drug resistance. CONCLUSION: SP cells with inherently high resistance to chemotherapeutic agents do exist in pancreatic cancers, which may be candidate cancer stem cells contributing to the relapse of the tumor.

同期刊论文项目
同项目期刊论文